Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Arveux

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
European Journal of Cancer Care|May 8, 2013
Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based studyT S Dabakuyo, A Arnaud, P Maingon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancerF Bonnetain, O Bouché, P Michel, et al.
Gastroenterologie Clinique Et Biologique|January 22, 2000
[Reporting of resected colonic carcinomas. Assessment of practices in 8 French counties in 1995]F Papin, J Maurel, P Grosclaude, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1996
Multiple primary cancers and estimation of the incidence rates and trendsK Filali, G Hédelin, P Schaffer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2012
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matchingI Le Ray, S Dabakuyo, G Crehange, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2003
Viral infection, atopy and mycosis fungoides: a European multicentre case-control studyM M Morales, J Olsen, P Johansen, et al.
Breast (Edinburgh, Scotland)|March 12, 2013
Waiting time disparities in breast cancer diagnosis and treatment: a population-based study in FranceF Molinié, C Leux, P Delafosse, et al.
Statistical Methods in Medical Research|March 17, 2010
Multi-state Markov models in cancer screening evaluation: a brief review and case studyZ Uhry, G Hédelin, M Colonna, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|August 19, 2005
[Ovarian cancer: incidence and mortality in France]B Trétarre, L Remontet, F Ménégoz, et al.
International Journal of Cancer|June 22, 2000
National cancer prevalence estimation in FranceM Colonna, G Hedelin, J Esteve, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
European Journal of Cancer Care|May 8, 2013
Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based studyT S Dabakuyo, A Arnaud, P Maingon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancerF Bonnetain, O Bouché, P Michel, et al.
Gastroenterologie Clinique Et Biologique|January 22, 2000
[Reporting of resected colonic carcinomas. Assessment of practices in 8 French counties in 1995]F Papin, J Maurel, P Grosclaude, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1996
Multiple primary cancers and estimation of the incidence rates and trendsK Filali, G Hédelin, P Schaffer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2012
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matchingI Le Ray, S Dabakuyo, G Crehange, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2003
Viral infection, atopy and mycosis fungoides: a European multicentre case-control studyM M Morales, J Olsen, P Johansen, et al.
Breast (Edinburgh, Scotland)|March 12, 2013
Waiting time disparities in breast cancer diagnosis and treatment: a population-based study in FranceF Molinié, C Leux, P Delafosse, et al.
Statistical Methods in Medical Research|March 17, 2010
Multi-state Markov models in cancer screening evaluation: a brief review and case studyZ Uhry, G Hédelin, M Colonna, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|August 19, 2005
[Ovarian cancer: incidence and mortality in France]B Trétarre, L Remontet, F Ménégoz, et al.
International Journal of Cancer|June 22, 2000
National cancer prevalence estimation in FranceM Colonna, G Hedelin, J Esteve, et al.
Pageof 10